Inventor
LOVENBERG TIMOTHY W
US31 patents
⚠️ This page may combine multiple inventors who share the name “LOVENBERG TIMOTHY W”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ORTHO MCNEIL PHARM INC
11 patentsUS6140354AOct 31, 2000
N-substituted aminotetralins as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders
ORTHO MCNEIL PHARM INC152 citations98
US6291476B1Sep 18, 2001
Pyrazole carboxamides useful for the treatment of obesity and other disorders
ORTHO MCNEIL PHARM INC47 citations94
US6201025B1Mar 13, 2001
N-aralkylaminotetralins as ligands for the neuropeptide Y Y5 receptor
ORTHO MCNEIL PHARM INC35 citations92
US6803362B2Oct 12, 2004
Heterocyclic compounds
ORTHO MCNEIL PHARM INC38 citations91
US6489337B1Dec 3, 2002
Method for treating histamine H3 receptor-mediated disorders with 2- or 3-aryl substituted imidazo[1,2-a] pyridines
ORTHO MCNEIL PHARM INC9 citations74
US6436939B2Aug 20, 2002
Method for using 2-aryloxyalkylaminobenzoxazoles and 2-aryloxyalkylaminobenzothiazoles as H3 antagonists
ORTHO MCNEIL PHARM INC8 citations74
US6855560B1Feb 15, 2005
Method of identifying compounds that modulate human histamine H3 receptor
ORTHO MCNEIL PHARM INC7 citations72
US7179604B2Feb 20, 2007
Methods of use of DNA encoding a human histamine receptor of the H3 subtype
ORTHO MCNEIL PHARM INC1 citations61
US7265135B2Sep 4, 2007
2-oxy, 2-amino, and 2-thio-imidazole compounds
ORTHO MCNEIL PHARM INC6 citations60
US7151200B2Dec 19, 2006
Histamine receptor H3 modified transgenic mice
ORTHO MCNEIL PHARM INC0 citations51
US7049401B1May 23, 2006
Human histamine receptor of the H3 subtype
ORTHO MCNEIL PHARM INC0 citations51
JANSSEN PHARMACEUTICA NV
6 patentsUS6951882B2Oct 4, 2005
Substituted 4-phenyl-[1,3]-dioxanes
JANSSEN PHARMACEUTICA NV17 citations83
US7893197B2Feb 22, 2011
Relaxin-3 chimeric polypeptides and their preparation and use
JANSSEN PHARMACEUTICA NV3 citations58
US7915420B2Mar 29, 2011
Aryl piperidine amides
JANSSEN PHARMACEUTICA NV0 citations51
US7618786B2Nov 17, 2009
Method for identifying modulators of human orexin-2 receptor
JANSSEN PHARMACEUTICA NV0 citations50
US7754882B2Jul 13, 2010
Hexahydro-pyrrolo-isoquinoline compounds
JANSSEN PHARMACEUTICA NV0 citations48
US7728107B2Jun 1, 2010
Canine 5-hydroxytryptamine 2A and 2B receptor
JANSSEN PHARMACEUTICA NV0 citations45
NEUROCRINE BIOSCIENCES INC
4 patentsUS5786203AJul 28, 1998
Isolated nucleic acid encoding corticotropin-releasing factor2 receptors
NEUROCRINE BIOSCIENCES INC41 citations89
US6239268B1May 29, 2001
Interleukin-1 type 3 receptors
NEUROCRINE BIOSCIENCES INC6 citations69
US6723841B2Apr 20, 2004
Corticotropin-releasing factor2 receptors
NEUROCRINE BIOSCIENCES INC1 citations60
US7034118B2Apr 25, 2006
Corticotropin-releasing factor2 receptors
NEUROCRINE BIOSCIENCES INC0 citations49
ORTHO PHARMA CORP
3 patentsUS6136559AOct 24, 2000
DNA encoding as human histamine receptor of the H3 subtype
ORTHO PHARMA CORP28 citations94
US6437100B1Aug 20, 2002
DNA encoding a human histamine receptor of the H3 subtype
ORTHO PHARMA CORP4 citations72
US6413743B1Jul 2, 2002
DNA encoding a human histamine receptor of the H3 subtype
ORTHO PHARMA CORP4 citations72